Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Immunoperoxidase techniques were used to obtain information about the possible presence of serum factors in senile plaques. We found only in plaques consisting of an amyloid core surrounded by a corona of degenerating neurites small amounts of IgG and light chains (kappa and lambda). These immunoglobulins were principally localized in the corona and not in the central amyloid core. Further it was found that all plaques contain the complement factors C1q, C3b, C3c, C3d and C4. Senile plaques lacked C5, C3 pro-activator and properdin. The possible significance of these findings in the genesis of the senile plaques and amyloid formation is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated microglia along with immunoglobulins and complement components are closely associated with Aβ deposits in brains from AD patients and AD mouse models (58)(59)(60)(61)(62).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [58]
Citations
Cites
Histochemistry: Theoretical and Applied
(1953) · Journal of the American Medical Association · doi:10.1001/jama.1953.02940280072039 · Cited by 7,021
ON THE BINDING OF CONGO RED BY AMYLOID
PUCHTLER, H., SWEAT, F., & LEVINE, M. (1962) · Journal of Histochemistry & Cytochemistry · doi:10.1177/10.3.355 · Cited by 1,128
Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration
Avrameas, S., & Ternynck, T. (1971) · Immunochemistry · doi:10.1016/0019-2791(71)90395-8 · Cited by 862
Kaplan, M. H., & Volanakis, J. E. (1974) · PubMed · Cited by 563
Glynn, L. E. (1981) · PubMed Central · Cited by 412
Interaction of C-Reactive Protein Complexes with the Complement System
Kaplan, M. H., & Volanakis, J. E. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.112.6.2135 · Cited by 405
ALZHEIMER'S DISEASE AND RELATED DISORDERS
Raskind, M. A., & Peskind, E. R. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70341-2 · Cited by 161
Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques
Ishii, T., & Haga, S. (1976) · Acta Neuropathologica · doi:10.1007/bf00685368 · Cited by 142
Ishii, T., Haga, S., & Shimizu, F. (1975) · Acta Neuropathologica · doi:10.1007/bf00689569 · Cited by 110
Research works printed but not linked: 6
- Boorsma DM, Streefkerk JG (1978) Improved method for separation of peroxidase conjugates. In: Knapp W, Holubar, K, Wick G (eds) Immunofluorescence and related staining techniques. Elsevier-North Holland Biochemical Press Amsterdam, pp 225?235
- Boorsma DM, Streefkerk JG (1976a) Some aspects of the preparation, analysis and use of peroxidase-antibody conjugates in immunohistochemistry. In: Pecters H (ed) Protides of the biological fluids, vol 24. Pergamon Press, Oxford, pp 795?802
- Davis BJ, Ornstein L (1959) High resolution enzyme localization with a new diazo reagent, ?hexazonium Pararosaniline?. J Histochem Cytochem 7:297?298
- Divry P (1927) Etude histochimique des plaques seniles. J Belge Nerol 27:643?657
- Stam FC (1965) Histochemistry of the senile involution of the brain. In: Vtn Int Congr Neuropathol Proc. Excerpta Medica, Amsterdam, pp 513?517
- Wigboldus JM (1959) Over de aard en genese van de plaques seniles. Thesis. Dijkstra's Drukkerij N.V., Groningen
Cited by
Items 301–400 of 453
McRae‐Degueurce, A., Dahlström, A. B., Polinsky, R. J., & Ling, E. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90139-h · Cited by 17
Complement System in Central Nervous System Disorders
Shin, M. L., Rus, H., & Niculescu, F. I. (1998) · CRC Press eBooks · doi:10.1201/b14212-24 · Cited by 18
Li, M., Ma, Y., Guo, Y., Liu, J.-Y., Tan, L., & Initiative, O. B. O. A. D. N. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01377-5 · Cited by 20
“The participation of complement proteins in the formation of amyloid plaques in AD patients has been identified in an autopsy report [12].”
BackgroundAmyloid β induces cellular relocalization and production of agrin and glypican-1
Timmer, N., van Horssen, J., Otte‐Höller, I., Wilhelmus, M. M. M., David, G., van Beers, J. J. B. C., de Waal, R. M. W., & Verbeek, M. M. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.063 · Cited by 24
Transport of Drugs Across the blood–brain Barrier in Alzheimer‘s Disease
Nicolazzo, J. A., & Mehta, D. C. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.41 · Cited by 22
Using animal models to determine the significance of complement activation in Alzheimer's disease.
Loeffler, D. A. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-18 · Cited by 19
Neuroinflammation and Alzheimer’s Disease
Eikelenboom, P. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5405-9_3 · Cited by 17
Self-citationGonzález‐Sánchez, M., Díaz, T., Pascual, C., Antequera, D., Martín, A. H. S., Velasco, S. L., Villarejo‐Galende, A., Bartolomé, F. B., & Carro, E. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1039-3 · Cited by 17
Hooper, C., Barreto, P. D. S., Cantet, C., Cesari, M., Payoux, P., Salabert, A., & Vellas, B. J. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.04.014 · Cited by 21
Microanalysis of Senile Plaques Using Nuclear Microscopy
Landsberg, J. P., McDonald, B., Grime, G. W., & Watt, F. (1993) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879300600206 · Cited by 18
Immunological Associations in Familial and Non-Familial Alzheimer Patients and Their Families
Frecker, M. F., Pryse-Phillips, W. E. M., & Strong, H. (1994) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100049027 · Cited by 19
Distribution of peripheral lymphocytes in Alzheimer patients and controls
Dysken, M. W., Minichiello, M. D., Hill, J., Skare, S. S., Little, J. T., Molchan, S. E., & Sunderland, T. (1992) · Journal of Psychiatric Research · doi:10.1016/0022-3956(92)90024-i · Cited by 16
Sato, M., Ikeda, K., Haga, S., Allsop, D., & Ishii, T. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90702-u · Cited by 15
Lemere, C. A., Grenfell, T. J., & Selkoe, D. J. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65095-x · Cited by 15
Do Nonsteroidal Anti-Inflammatory Drugs Have a Protective Effect Against Dementia?
Muiswinkel, F. L. V., & Eikelenboom, P. (1996) · Drugs & Aging · doi:10.2165/00002512-199609010-00001 · Cited by 17
Self-citationComplement in diseases of the nervous system
Morgan, B. P. (1993) · Springer eBooks · doi:10.1007/978-94-011-2214-6_13 · Cited by 17
Yu, L., Che, R., Zhang, W., Xu, J., Lian, W., He, J., Tu, S., Bai, X., & He, X. (2023) · Phytotherapy Research · doi:10.1002/ptr.7765 · Cited by 16
“Through pathological examination, they discovered the presence of large amounts of inflammatory factors in SP (Eikelenboom & Stam, 1982).”
BackgroundInterleukin‐2 receptor in peripheral blood lymphocytes of Alzheimer's disease patients
Ikeda, T., Yamamoto, K., Takahashi, K., Kaneyuki, H., & Yamada, M. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03141.x · Cited by 14
Zou, W., Kou, L., Wang, Y., Jin, Z., Xiong, N., Wang, T., & Xia, Y. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01005-z · Cited by 17
“ComplementcomponentssuchasC1qandC3,aswellaspro-in fl ammatory cytokines IL-1, IL-6, and TNF-α , were fi rst detected in amyloid plaques of AD patients 27,28 .”
Insights from the neural guidance factor Netrin-1 into neurodegeneration and other diseases
Cai, M., Zheng, Q., Chen, Y., Liu, S., Zhu, H., & Bai, B. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1379726 · Cited by 16
“First, in AD brain cortices, complement system protein components C1q, C3b, C3c, C3d, and C4 are found to localize within the amyloid plaques (Eikelenboom and Stam, 1982), and fibrillar A β peptides and neurofibrillary tangles can activate directly the complements in vitro (Tenner, 2020).”
BackgroundTherapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease
Serradas, M. L., Ding, Y., Martorell, P., Kulińska, I., & Castro‐Gomez, S. (2024) · Cells · doi:10.3390/cells13171426 · Cited by 17
“The first piece of evidence linking the complement to AD came from studies, in which plaques and periplaque areas stained positive for complement proteins and activation products [126,139].”
BackgroundThe pelvic girdle pain deadlock: 1. Would ‘deconstruction’ help?
Meijer, O. G., Hu, H., Wu, W. H., & Prins, M. R. (2020) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2020.102169 · Cited by 14
Panayiotou, E., Fella, E., Papacharalambous, R., Malas, S., Saraiva, M. J., & Kyriakides, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175767 · Cited by 16
Complement activation by the amyloid proteins Aβ peptide and β2-microglobulin
Nybo, M., Nielsen, E. H., & Svehag, S.-E. (1999) · Amyloid · doi:10.3109/13506129909007338 · Cited by 13
Honda, S., Itoh, F., Yoshimoto, M., Ohno, S., Hinoda, Y., & Imai, K. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.5.m265 · Cited by 13
C3 and haptoglobin polymorphism in dementia of the Alzheimer type
Eikelenboom, P., Vink‐Starreveld, M. L., Jansen, W., & Pronk, J. C. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb02478.x · Cited by 13
Self-citationSanders, O. D. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220047 · Cited by 13
Lucca, U. (1999) · CNS Drugs · doi:10.2165/00023210-199911030-00005 · Cited by 14
The pathology of dementias: an overview
Alafuzoff, I. I. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb04447.x · Cited by 15
Cellular ageing of Alzheimer's disease and Down syndrome cells in culture.
Carmeliet, G., David, G., & Cassiman, J. (1991) · Mutation research · doi:10.1016/0921-8734(91)90013-2 · Cited by 12
Epistasis analysis links immune cascades and cerebral amyloidosis
Initiative, A. D. N., Benedet, A. L., Labbe, A., Lemay, P., Zimmer, E. R., Pascoal, T. A., Leuzy, A., Mathotaarachchi, S. S., Mohades, S., Shin, M., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0436-z · Cited by 14
“of AD biomarkers [4] has not explored the role of neuroinflammation, a phenomenon implicated in the pathogenesis of AD by several lines of evidence [5–7].”
BackgroundThe Neuritic Dystrophy of Alzheimer’s Disease: Degeneration or Regeneration?
Kosik, K. S. (1991) · Springer eBooks · doi:10.1007/978-3-642-46722-6_20 · Cited by 11
Immunization of Rats With Cholinergic Neurons Induces Behavioral Deficits
Chapman, J., Feldon, J., Alroy, G., & Michaelson, D. M. (1989) · Neural Plasticity · doi:10.1155/np.1989.63 · Cited by 11
In VitroAmyloid Fibril Formation from α1-Antitrypsin
Janciauskiene, S. M., Carlemalm, E., & Eriksson, S. (1995) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1995.376.2.103 · Cited by 11
Shi, X., Ren, S., Zhang, B., Guo, S., He, W., Yuan, C., Yang, X., Ig-lzevbekhai, K., Sun, T., Wang, Q., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90982-1 · Cited by 9
Cochran, F. R., & Vitek, M. P. (1996) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.5.4.449 · Cited by 12
Eikelenboom, P., Scott, J. R., McBride, P., Rozemüller, A. J. M., Bruce, M. E., & Fraser, H. (1987) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890250 · Cited by 10
Self-citationDaskoulidou, N., Carpanini, S. M., Zelek, W. M., & Morgan, B. P. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_524 · Cited by 12
Rodríguez-López, A., Esteban, D., Domínguez‐Romero, A. N., & Gevorkian, G. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115189 · Cited by 9
Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
Sulatsky, M. I., Stepanenko, O. V., Stepanenko, O. V., & Sulatskaya, A. I. (2025) · Aggregate · doi:10.1002/agt2.70078 · Cited by 11
The complement cascade in Alzheimer’s disease: modern implications of an ancient immune protagonist
Papavergi, M.-T., Bathini, P., Singh, B. B., & Lemere, C. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00916-y · Cited by 13
“Insights into complement involvement in AD began in the 1980s, when Eikelenboom and Stam reported the presence of complement proteins within amyloid plaques in late-stage AD postmortem brain tissue for the first time [154].”
Hasantari, I., Nicolas, N., Alzieu, P., Leval, L., Shalabi, A., Grolleau, S., & Dinet, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042272 · Cited by 12
“Several studies have noted that the pathological changes characterizing AD could all result from complement activation in neuritic A β plaques; since the complement system activates various cell types with the release of cytokines, it alters cellular functions and induces cell damage [14–16].”
BackgroundNeedham, E., & Zandi, M. S. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7473-x · Cited by 9
Lin, X., Bai, G., Lin, L., Wu, H., Cai, J., Ugen, K. E., & Cao, C. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28735 · Cited by 10
“Identification and mapping of linear antigenic determinants of human amyloid ß(1-42) peptide.”
BackgroundThe Pathophysiology of Alzheimer’s Disease
Selkoe, D. J. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_4 · Cited by 16
Heinonen, O., Syrjänen, S., Soininen, H., Talasniemi, S., Kaski, M., Mäntyjärvi, R. A., Syrjänen, K. J., & Riekkinen, P. J. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90349-p · Cited by 9
Peripheral Markers in Alzheimer’s Disease
Sweet, R. A., & Zubenko, G. S. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_22 · Cited by 9
Soininen, H. S., Heinonen, O., Hallikainen, M., Hänninen, T., Koivisto, K. J., Syrjänen, S., Talasniemi, S., & Riekkinen, P. J. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260920 · Cited by 9
Huang, D., Martin, M. E., Hu, D., Roses, A. D., Goldgaber, D., & Strittmatter, W. J. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90192-2 · Cited by 8
Scintigraphic visualization of inflammation in neurodegenerative disorders
Versijpt, J. J., Laere, K. V., Dierckx, R. A., Dumont, F., Deyn, P. P. D., Slegers, G., & Korf, J. (2003) · Nuclear Medicine Communications · doi:10.1097/00006231-200302000-00014 · Cited by 9
McDonald, B., Esiri, M. M., & McIlhinney, R. A. J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08276.x · Cited by 8
Wang, J., Wu, J., Ma, X., Wu, Y., Xiao, Z., Zhou, X., Ding, D., & Zhao, Q. (2025) · Aging and Health Research · doi:10.1016/j.ahr.2025.100267 · Cited by 7
Shibata, M., Makioka, K., Nakamura, T., Kasahara, H., Yamazaki, T., Takatama, M., Okamoto, K., & Ikeda, Y. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137642 · Cited by 7
Innate immunity in the nervous system
Ramaglia, V., & Baas, F. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17507-6 · Cited by 8
“…complement receptor-related protein y (sCrry) in the brain show increased Ab accumulation and neurodegeneration a. Eikelenboom et al. (1989), Eikelenboom and Stam (1982, 1984), McGeer et al. (1989), Veerhuis et al. (1995), Webster et al. (1997a), McGeer and McGeer (2002) b. Bradt et al.…”
BackgroundPopović, M., Jovanova-Nešić, K., Popović, N., Ugrešić, N. D., Kostić, V., & Rakić, L. (1997) · International Journal of Neuroscience · doi:10.3109/00207459708988472 · Cited by 7
Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease
Oh, C.-K., Wang, Y., & Lipton, S. A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00707 · Cited by 8
“Complement proteins such as C1q, C3b, C4b, and properdin colocalize with fibrillar A β plaques in both human AD and mouse model brains, suggesting in vivo activation of these pathways [118 – 122].”
Xue, R., Gao, P., Chen, Y.-M., Liu, Y., Han, B., Huang, Y., Mi, Y., Cui, R., Lin, Y., Wang, Z.-T., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251322808 · Cited by 6
“…the ability to trigger both classical and alternative complement pathways, 11 – 13 and in human AD and mouse disease models, complement cascade proteins such as C1q, C3b, C4b and prepropeptide co-localize with pro-fi bronectin A β plaques, 37 – 41 demonstrating the activation of this system in vivo.”
Complement in Health and Disease
Liu, C., & Ahearn, J. M. (2005) · Elsevier eBooks · doi:10.1016/b978-012455900-4/50273-7 · Cited by 6
Human Cord Blood Serum-Derived APP α-Secretase Cleavage Activity is Mediated by C1 Complement
Habib, A., Sawmiller, D. R., Hou, H., Kanithi, M., Tian, J., Jin, Z., Zi, D., He, Z., Sanberg, P. R., & Tan, J. (2018) · Cell Transplantation · doi:10.1177/0963689718775941 · Cited by 6
Humoral and Cellular Immunologic Repertoire in Alzheimer's Disease
Amaducci, L. A., Falcini, M., & LIPPI, A. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb38678.x · Cited by 6
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Immunoneurology: A Serum Protein Afferent Limb to the CNS
Kozlowski, G. P., Nilaver, G., & Zloković, B. V. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5799-5_22 · Cited by 6
Su, W.-S., Wu, M.-T., Cheng, I. H.-J., & Yang, F. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115420 · Cited by 5
Zhou, J., Wang, Z., Sun, Y., Fu, Y., Li, D., Tan, L., & Initiative, A. D. N. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230513 · Cited by 6
“…modulating AD pathology, as demonstrated by previous studies that found co-localization of C4 and amyloid plaques, and our study found a strong association between C4 and AD pathology, but further studies are needed to confirm the details between C4 and AD pathology and cognitive function [39, 41].”
Jacob, C., Tollenaere, M., Kachar, H., Potier, M., Deyn, P. P. D., & Dam, D. V. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41445 · Cited by 6
“Microglial and astrocytic activation, increased inflammatory gene expression, formation of immune complexes, and cerebral oxidative stress have been reported to occur at different ages in DS [76 – 83].”
The association of serum immunoglobulins with cognition and dementia: the Rotterdam Study
Khan, S. R., Yaqub, A., Ikram, M. K., van Hagen, P. M., Peeters, R. P., Dalm, V. A. S. H., Chaker, L., & Ikram, M. A. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11374-7 · Cited by 7
“Aggregates of IgG have also been found in the corona of cerebral amyloid plaques [20, 21].”
BackgroundQi, X., Liu, Y., Chi, H., Yang, Y., Xiong, Q., Li, M., Yao, R., Sun, H., Li, Z., & Zhang, J. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137318 · Cited by 5
Alzheimer's disease--immunological aspects.
Leszek, J., Dobrzańska, I., & Gąsiorowski, K. (1993) · PubMed · Cited by 5
Inflammation, Free Radicals, Glycation, Metabolism and Apoptosis, and Heavy Metals
Mattson, M. P. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50025-1 · Cited by 6
Molecular Pathobiology of Alzheimer’s Disease
Harrington, C. R., & Wischik, C. M. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_13 · Cited by 5
The Blood-Brain Barrier in Cerebral Amyloidogenesis in Alzheimer’s Disease and Scrapie
Eikelenboom, P., Fraser, H., Rozemüller, A. J. M., & Stam, F. C. (1988) · Springer eBooks · doi:10.1007/978-3-642-46634-2_4 · Cited by 4
Self-citationAlzheimer’s Disease: From Pathogenesis to Emerging Therapeutic Targets
Takahashi, T., & Muguruma, K. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062357 · Cited by 4
“Complement components, including C1q, localize to senile plaques, as demonstrated in early neuropathological studies conducted in the 1980s [89,90].”
Sarlus, H., Codita, A., Wang, X., Cedazo-Mínguez, Á., Schultzberg, M., & Oprica, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.005 · Cited by 3
“The present results showed that 3xTgAD mice had higher basal levels of C1qC than the background strain, in agreement with increased complement activation in AD brain (Eikelenboom and Stam, 1982; Wyss-Coray and Rogers, 2012).”
BackgroundResultSuche nach Risikogenen bei der Alzheimer-Erkrankung
Karaca, I., Wagner, H., & Ramírez, A. (2017) · Der Nervenarzt · doi:10.1007/s00115-017-0354-7 · Cited by 3
“Bei Trägern dieser Varianten konnten ein stärkerer Abbau der kognitiven Leistungsfähigkeit [31], eine höhere Plaquebelastung [60] undmehrKomplementfaktoren in den betroffenenHirnregionennachgewiesenwerden [9].”
Yakupova, E. I., Bobyleva, L. G., Vikhlyantsev, I. M., & Bobylev, A. G. (2020) · BIOPHYSICS · doi:10.1134/s000635092001025x · Cited by 3
Serum immunoglobulins and biomarkers of dementia: a population-based study
Yaqub, A., Khan, S. R., Vernooij, M. W., van Hagen, P. M., Peeters, R. P., Ikram, M. A., Chaker, L., & Dalm, V. A. S. H. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01333-3 · Cited by 4
“Several studies have previously shown that high levels of IgG are found in serum, cerebrospinal fluids and brains of post-mortem patients with Alzheimer’s disease [36, 37].”
BackgroundSPECT/PET Findings in Lewy Body Dementia
Ducksbury, R., Whitfield, T. J., & Walker, Z. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_17 · Cited by 4
McRae‐Degueurce, A., & Ling, E. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.2.247 · Cited by 3
SPECT/PET Findings in Dementia with Lewy Bodies
Zabihi, S., Whitfield, T. J., & Walker, Z. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_17 · Cited by 3
Complement and Complement Reactions
Berger, M., Hammer, C. H., Cole, F. S., Colten, H. R., Bürger, R., Rittner, C. K., Schneider, P. M., Loos, M., Vogt, W., Götze, O., et al. (1988) · Springer eBooks · doi:10.1007/978-3-642-97038-2_2 · Cited by 4
Weggen, S., Czirr, E., Leuchtenberger, S., & Eriksen, J. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_11 · Cited by 4
Complement allotypes in familial and sporadic alzheimer's disease
Panegyres, P. K., & Dawkins, R. L. (1991) · Journal of Neurology · doi:10.1007/bf00315331 · Cited by 3
Kametani, F., Tanaka, K., Sato, M., Haga, S., Saitoh, T., Shinoda, T., & Ishii, T. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90120-x · Cited by 3
New cerebrospinal fluid biomarkers in Alzheimer’s disease
Burchell, J. T., & Panegyres, P. K. (2017) · Future Neurology · doi:10.2217/fnl-2017-0009 · Cited by 3
Complement biosynthesis in human brain: Insights from single-nucleus transcriptomics of hippocampusPreprint
Nguyen, V. D., Bright, M., Zhou, Y., Morgan, B. P., & Zelek, W. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.06.652374 · Cited by 3
Nimmo, J., Bright, M., Yang, Z., Nicholls, L. E., Morgan, B. P., Daskoulidou, N., & Zelek, W. M. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10199-3 · Cited by 4
“…products (C1q, C3 and C5b-9) in hallmark lesions of neurodegeneration; on amyloid beta (Aβ) plaques in AD, on drusen deposits in AMD, and damaged retinal ganglion cells (RGC) in glaucoma (Anderson et al. 2002; Eikelenboom and Stam 1982; Katschke et al. 2018; Tezel et al. 2010; Veerhuis 2011).”
Micronutrients in the Prevention and Improvement of the Standard Therapy for Alzheimer’s Disease
Prasad, K. N. (2019) · CRC Press eBooks · doi:10.1201/9780429243462-9 · Cited by 4
Genetic markers involved in neuroinflammation in Down syndrome: a systematic review
Silva, M. D. A. E., Lula, M. D., Felício, L. R., dos Santos, B. R. A., Nassif, L. S., Borin, M. C., Álvares-Teodoro, J., Acúrcio, F. D. A., & Guerra, A. A. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-0251 · Cited by 3
“This condition may lead to brain tissue damage and foster a neuroinflammatory environment that correlates with accelerated cognitive decline and dementia development in individuals with DS 66,67 .”
12th International Conference on Alzheimer's Disease (ICAD), Vienna, Austria
Strobel, G. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1250 · Cited by 2
“Complement activation around amyloid plaques has been spotted even during the early wave of interest in inflammation in AD [10].”
Eisel, U. L. M., Dobos, N., Dierckx, R., Luiten, P. G. M., & Korf, J. (2010) · Neuroimmune biology · doi:10.1016/s1567-7443(10)70025-9 · Cited by 2
Current and future treatments of memory complaints and Alzheimer’s disease
Summers, W. K. (2011) · Therapy · doi:10.2217/thy.11.60 · Cited by 5
Cellular and molecular mechanisms of Alzheimer’s disease inflammation
Peery, H. E., Strohmeyer, R., & Rogers, J. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_1 · Cited by 2
Chronische pijn: een doorbraak?
Meijer, O. G., Prins, M. R., & Dantzer, R. (2017) · Neuropraxis · doi:10.1007/s12474-017-0156-5 · Cited by 2
Blood Brain Barrier Dysfunction and Cerebrovascular Degeneration in Alzheimer’s Disease
Kalaria, R. N. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_11 · Cited by 2
Study of the complement activation by amyloid aggregates of smooth muscle titin in vitro
Yakupova, E. I., Bobylev, A. G., Bobyleva, L. G., & Vikhlyantsev, I. M. (2019) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2019.1694943 · Cited by 2
Functional Imaging and Psychopathological Consequences of Inflammation in Alzheimer’s Dementia
Versijpt, J. J., Dierckx, R., & Korf, J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-888-5_7 · Cited by 2
Easing the burden of Alzheimer's disease: therapeutic options
Baumel, B. S. (1998) · European Journal of Neurology · doi:10.1111/j.1468-1331.1998.tb00445.x · Cited by 2
Amyloid β peptide: A century of discoveries
Abraham, C. R. (2000) · Amyloid · doi:10.3109/13506120009146814 · Cited by 3
Giavarotti, L. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2016.tde-26082016-150838 · Cited by 2
Neuroinflammation in depression
Dobos, N. (2014) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Metadata
- Authors
- Eikelenboom, P., & Stam, F. C.
- Affiliations
- Vrije Universiteit Amsterdam (NL)
- ORCID
- Eikelenboom, P.
- Venue
- Acta Neuropathologica
- Published
- 1982
- Volume
- 57
- Issue
- 2-3
- Pages
- 239-242
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2312933856
- Cited by
- 454
- References
- 24
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 23 · 2019: 13 · 2018: 13 · 2017: 11 · 2016: 9 · 2015: 7 · 2014: 16 · 2013: 7 · 2012: 11
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- amyloid plaques, Alzheimer's disease, immunoglobulins, complement proteins, amyloid core, neurite degeneration, IgG, kappa light chain, lambda light chain, C1q, C3b, C3c, C3d, C4, C5, properdin, amyloid fibril formation
- MeSH terms
- Alzheimer Disease, Amyloid, Cerebral Cortex, Complement System Proteins, Dementia, Humans, Immunoglobulin G, Immunoenzyme Techniques, Immunoglobulins, Immunoglobulin Fc Fragments, Immunoglobulin gamma-Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.